Skip to main content
. 2015 Jan 17;15:10. doi: 10.1186/s12889-014-1339-0

Table 4.

Respondent willingness to participate in clinical trials (N = 1,515)

Variable n (%) x 2 p
Gender Male 204/753 (27.1) 3.665 .056a
Female 174/762 (22.8)
Age (years) 19~29 64/295 (21.7) 1.205 .272b
30’s 89/375 (23.7)
40’s 114/411 (27.7)
50’s 68/250 (27.2)
≥60 43/184 (23.4)
Education ≤ High school 240/958 (25.1) 0.014 .905a
≥ College 138/557 (24.8)
Resident areas Large city 190/720 (26.4) 3.161 .075b
Small city 155/623 (24.9)
Rural area 33/172 (19.2)
Household income <2,000 89/347 (25.6) 0.213 .644b
(1,000 won/month) 2,000 ∼ 2,999 109/406 (26.8)
3,000 ∼ 3,999 79/353 (22.4)
≥4,000 97/390 (24.9)
Living style Alone 26/76 (32.9) 2.834 .092a
With family 351/1433 (24.5)
Perception on ultimate beneficiary of CT Pharmaceutical company 85/463 (18.4) 18.473 <.001a
Hospital or physician 30/136 (22.1)
Patients 195/678 (28.8)
Advances in medicine 68/236 (28.8)
Experience of CT participation No 302/1114 (27.1) 4.131 .042a
Yes 11/24 (45.8)
Awareness of CT No 65/377 (17.2) 15.929 <.001a
Yes 313/1138 (27.5)
Favorable feeling toward CT Low 25/327 (7.6) 157.311 <.001b
Moderate 128/680 (18.8)
High 225/508 (44.3)
Safety toward CT Low 28/410 (6.8) 240.003 <.001b
Moderate 189/848 (22.3)
High 161/257 (62.6)
Necessity toward CT Low 2/87 (2.3) 63.434 <.001b
Moderate 52/366 (14.2)
High 324/1062 (30.5)

aPearson x 2. bLinear-by-linear association.